Company Filing History:

8 out of 2,937

Merck Patent Gmbh

patents

1 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 2008-2012

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8247448 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2012-08-21),

2. 8063067 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2011-11-22),

3. 7863328 - Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof (2011-01-04),

4. 7820847 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2010-10-26),

5. 7678831 - Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2010-03-16),

6. 7632846 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2009-12-15),

7. 7491747 - Butyric acid derivatives (2009-02-17),

8. 7482484 - Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia (2009-01-27),

9. 7465752 - Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2008-12-16),

Title: Valérie Guyard-Dangremont: Innovator in Pharmaceutical Chemistry

Introduction

Valérie Guyard-Dangremont is a notable inventor based in Saint Maurice de Gourdans, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various health conditions. With a total of nine patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Guyard-Dangremont's latest patents include innovative formulations and processes related to butenoic acid derivatives. These compounds are designed for the treatment of dyslipidaemia, atherosclerosis, and diabetes. His work on hexenoic acid derivatives also focuses on similar therapeutic applications, showcasing his commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Valérie has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

He has collaborated with esteemed colleagues such as Francis Contard and Daniel Guerrier, further enhancing the quality and reach of his inventions. These partnerships have played a crucial role in the development of his patented technologies.

Conclusion

Valérie Guyard-Dangremont stands out as a significant figure in pharmaceutical innovation. His contributions through patents and collaborations continue to influence the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.